CELLCONTROL BIOMEDICAL LAB AG has a total of 11 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are INDI MOLECULAR INC, BIOPHAGE INC and CANTOR THOMAS L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | Mexico | 1 | |
#6 | Poland | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Schlebusch Harald | 5 |
#2 | Wagner Uwe | 5 |
#3 | Kischkel Frank | 3 |
#4 | Luedde Mirko | 1 |
#5 | Babarina Alexandra | 1 |
#6 | Metzger Rainer | 1 |
#7 | Waldenmaier Dirk Sebastian | 1 |
#8 | Ludde Mirko | 1 |
#9 | Waldenmaier Dirk | 1 |
#10 | Kischkel Frank Christian | 1 |
Publication | Filing date | Title |
---|---|---|
DE10251879A1 | Medium for measuring effect of tumor therapy on individual cells, useful for selecting treatments, has low buffering capacity in which acidification caused by metabolism of carbon sources is monitored | |
WO03008530A2 | A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method | |
DE10210239A1 | Ab1 'specific antibodies against the tumor associated antigen CA125 | |
DE10154540A1 | Procedure for predicting or predicting the effectiveness of tumor treatment |